Brief: Nordic Nanovector Q2 Operating Loss Widens To NOK 113.4 Million

Thor Medical ASA

27/08/2020 06:04

Aug 27 (Reuters) - Nordic Nanovector ASA  NORN.OL :
    * IS TARGETING THE READOUT OF THREE-MONTH TOP LINE DATA FROM
PARADIGME IN H2’2021
    * Q2 OPERATING LOSS NOK 113.4 MILLION VERSUS LOSS NOK 111.0 
MILLION YEAR AGO
    * STEPS TAKEN TO CONSERVE CASH, INCLUDING REDUCING HEADCOUNT
AND
PAUSING CERTAIN CLINICAL TRIALS, WILL EXTEND CASH RUNWAY INTO
2021
    * EXPECTS TO SEE THE IMPACT OF THESE COST-SAVING INITIATIVES
EMERGE OVER THE REMAINDER OF 2020
    * NOW BELIEVES IT IS IN A MUCH-IMPROVED POSITION TO DELIVER
THE
PIVOTAL RESULTS FROM PARADIGME IN A TIMELY MANNER

Source text for Eikon:  ID:nWkrbkYNYw 
Further company coverage:  NORN.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))